<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-88010</identifier>
<setSpec>1138-3593</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Fixed drug eruption: diagnostic clues</dc:title>
<dc:description xml:lang="en">Fixed drug eruption (FDE) is a special variant of toxicoderma characterised by skin lesions and / or mucous which always occurs in the same location after oral administration of the causal agent, usually a drug. The diagnosis is mainly clinical, based on a thorough drug history and recognition of clinical features of this condition. There are several diagnostic tests that help confirm the diagnosis, such as applying a patch test on skin suspected drugs, the oral provocation test with oral drug intake and skin biopsy. We present three cases of fixed drug eruption and describe its clinical features and the diagnostic procedure followed in these cases (AU)</dc:description>
<dc:creator>Mejias-Boils, A</dc:creator>
<dc:creator>Messeguer, F</dc:creator>
<dc:creator>Alegre De Miquel, V</dc:creator>
<dc:creator>Agusti-Mejias, A</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">El eritema fijo medicamentoso (EFM) es una variante especial de toxicodermia caracterizada por la aparición de lesiones cutáneas y/o mucosas que presentan recurrencias siempre en la misma localización tras la administración oral del agente causal, normalmente un fármaco. El diagnóstico es fundamentalmente clínico, basado en una anamnesis farmacológica exhaustiva y en el reconocimiento de las manifestaciones clínicas características de esta entidad. Existen algunas pruebas diagnósticas que contribuyen a confirmar el diagnóstico, como la prueba del parche aplicando sobre la piel el fármaco sospechoso, la prueba de provocación oral con la toma del fármaco por vía oral y la biopsia cutánea. Presentamos 3 casos de EFM y describimos sus características clínicas y el procedimiento diagnóstico seguido en estos casos (AU)</dc:description>
<dc:source>SEMERGEN, Soc. Esp. Med. Rural Gen. (Ed. Impr.);37(4): 215-218, abr. 2011. ilus</dc:source>
<dc:identifier>ibc-88010</dc:identifier>
<dc:title xml:lang="es">Eritema fijo medicamentoso: claves diagnósticas</dc:title>
<dc:subject>^d8657^s22045</dc:subject>
<dc:subject>^d1731^s22074</dc:subject>
<dc:subject>^d30507^s22036</dc:subject>
<dc:subject>^d30694^s22016</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d30694^s22036</dc:subject>
<dc:subject>^d3965</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d4977^s22036</dc:subject>
<dc:subject>^d13807^s22000</dc:subject>
<dc:subject>^d673^s22020</dc:subject>
<dc:subject>^d29286^s22036</dc:subject>
<dc:subject>^d331</dc:subject>
<dc:subject>^d4977^s22012</dc:subject>
<dc:subject>^d673^s22000</dc:subject>
<dc:subject>^d30694^s22012</dc:subject>
<dc:subject>^d30694^s22067</dc:subject>
<dc:subject>^d13807^s22020</dc:subject>
<dc:subject>^d28145^s22020</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d28145^s22000</dc:subject>
<dc:type>article</dc:type>
<dc:date>201104</dc:date>
</metadata>
</record>
</ibecs-document>
